Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Published:2015-11-12 Issue:20 Volume:126 Page:2345-2347
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Sanchorawala Vaishali¹^ORCID,Sun Fangui²³,Quillen Karen¹^ORCID,Sloan J. Mark¹^ORCID,Berk John L.⁴^ORCID,Seldin David C.¹

Affiliation:

1. Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA

2. Amyloidosis Center, Boston University School of Medicine, and

3. Department of Biostatistics, Boston University School of Public Health, Boston, MA

4. Amyloidosis Center, Boston University School of Medicine, Boston, MA

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/20/2345/1389641/2345.pdf

Reference5 articles.

1. Molecular mechanisms of amyloidosis.;Merlini;N Engl J Med,2003

2. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.;Skinner;Ann Intern Med,2004

3. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.;Cibeira;Blood,2011

4. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.;Palladini;J Clin Oncol,2012

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

2. Treatment of AL amyloidosis in the era of novel immune and cellular therapies;Frontiers in Oncology;2024-06-28

3. Kidney Amyloidosis: Updates on Pathogenesis and Therapeutic Frontiers;American Journal of Nephrology;2024-06-12

4. Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy;Frontiers in Medicine;2024-05-02

5. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3